Novavax Logo
Novavax (NASDAQ: NVAX) is a Maryland-based biotech company making waves in the global vaccine landscape. Utilizing a unique recombinant nanoparticle technology, Novavax focuses on developing innovative vaccines to combat some of humanity's most challenging infectious diseases.
Their most prominent claim to fame is the Novavax COVID-19 Vaccine, Adjuvanted, a protein-based jab recently authorized for use in individuals 12 and older. ️ Unlike its mRNA counterparts, Novavax's vaccine takes a more traditional approach, presenting harmless copies of the spike protein to trigger an immune response. This has attracted interest from individuals seeking an alternative to mRNA vaccines.
Beyond COVID-19, Novavax has a robust pipeline filled with potential vaccines for influenza, respiratory syncytial virus (RSV), and even Ebola. As they continue their research and development efforts, Novavax stands poised to play a significant role in safeguarding public health around the world.
